My Legacy Advisors LLC Sells 1,775 Shares of HCA Healthcare, Inc. (NYSE:HCA)

My Legacy Advisors LLC cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 31.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,834 shares of the company’s stock after selling 1,775 shares during the period. My Legacy Advisors LLC’s holdings in HCA Healthcare were worth $1,558,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Terra Nova Asset Management LLC increased its stake in HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after buying an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV raised its position in HCA Healthcare by 7.4% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after purchasing an additional 29 shares during the period. Brookstone Capital Management increased its position in shares of HCA Healthcare by 0.7% in the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after acquiring an additional 30 shares during the period. UMB Bank n.a. boosted its stake in shares of HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares in the last quarter. Finally, Lake Street Advisors Group LLC boosted its stake in HCA Healthcare by 1.3% during the second quarter. Lake Street Advisors Group LLC now owns 2,732 shares of the company’s stock worth $878,000 after acquiring an additional 35 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

HCA stock traded down $1.95 during trading hours on Tuesday, hitting $408.81. 425,650 shares of the stock were exchanged, compared to its average volume of 1,135,621. The firm has a market capitalization of $107.07 billion, a P/E ratio of 20.27, a P/E/G ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $417.14. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a 50-day simple moving average of $393.16 and a two-hundred day simple moving average of $351.09.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same period last year, the company earned $4.29 earnings per share. The firm’s revenue was up 10.3% compared to the same quarter last year. On average, analysts forecast that HCA Healthcare, Inc. will post 22.51 earnings per share for the current fiscal year.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 17,202 shares of company stock worth $6,407,273. Insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HCA. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. Leerink Partners lifted their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Barclays boosted their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Finally, KeyCorp started coverage on shares of HCA Healthcare in a research note on Friday, October 11th. They set an “overweight” rating and a $475.00 target price for the company. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have assigned a strong buy rating to the company. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $367.15.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.